Article 3Information exchange related to the selection of medical devices and in vitro diagnostic medical devices for joint clinical assessment#
1.
2.The European Medicines Agency shall provide the information referred to in paragraph 1 no later than 15 days after the end of each quarter, pertaining to that quarter. For the first reporting period, the European Medicines Agency shall provide the information referred to in paragraph 1 covering the period from 1 January 2024.
Source: EUR-Lex, © European Union, 1998-2026. Reuse authorised under Decision 2011/833/EU.